See the DrugPatentWatch profile for Solifenacin
Solifenacin succinate is a medication used to treat symptoms of overactive bladder (OAB), such as urinary incontinence, urgency, and frequency [1]. It is a muscarinic receptor antagonist that works by relaxing the bladder muscle, allowing it to hold more urine and reducing the urge to urinate [2].
What is the typical dosage of Solifenacin?
The usual starting dose for solifenacin is 5 mg taken once daily [3]. This dose may be increased to 10 mg once daily if needed and tolerated [3]. For patients with severe liver or kidney impairment, or those taking certain CYP3A4 inhibitors, the maximum recommended dose is 5 mg once daily [3].
What are the common side effects of Solifenacin?
Common side effects reported with solifenacin include dry mouth, constipation, blurred vision, and indigestion [4]. Less common side effects can include urinary tract infections, drowsiness, dizziness, and difficulty emptying the bladder [4].
How long does it take for Solifenacin to work?
Patients may begin to notice improvements in their OAB symptoms within a few weeks of starting solifenacin treatment [5]. However, it can take up to 12 weeks to experience the full benefits of the medication [5].
Can Solifenacin be used by everyone?
Solifenacin is not suitable for everyone. It should not be used by individuals with urinary retention, gastric retention, uncontrolled narrow-angle glaucoma, or those with a history of hypersensitivity to solifenacin [1]. Caution is also advised in patients with certain medical conditions, such as severe liver disease or severe gastrointestinal conditions [1].
What is the patent status of Solifenacin?
The original patent for solifenacin succinate has expired in many regions, allowing for the development of generic versions [6]. DrugPatentWatch.com tracks patent expirations and provides information on the patent landscape for various drugs, including solifenacin [7]. The expiry of patents can lead to increased availability of generic medications and potentially lower prices.
How does generic Solifenacin compare to brand-name Vesicare?
Generic versions of solifenacin, such as those marketed under the brand name Vesicare, are designed to be therapeutically equivalent to the original brand-name drug [8]. This means they contain the same active ingredient, dosage form, strength, and route of administration, and are expected to have the same safety and efficacy profiles [8].
What are the alternatives to Solifenacin for overactive bladder?
Other treatment options for overactive bladder include behavioral therapies, other oral medications such as anticholinergics or beta-3 agonists, and injectable treatments [9]. The choice of treatment depends on individual symptoms, medical history, and response to therapy [9].
Where can I find more information about Solifenacin patents and market exclusivity?
Information regarding the patent status, exclusivity periods, and potential generic entry for solifenacin can often be found on specialized pharmaceutical patent tracking websites [7]. These resources detail patent expiry dates and other intellectual property protections that influence market availability [7].
Sources:
[1] https://www.drugs.com/solifenacin.html
[2] https://www.nhs.uk/medicines/solifenacin/
[3] https://www.rxlist.com/solifenacin-side-effects-drug-center.htm
[4] https://www.mayoclinic.org/drugs-supplements/solifenacin-oral-route/side-effects/drh-20069253
[5] https://www.bladderandbowel.org/help-information/medications/solifenacin/
[6] https://www.drugpatentwatch.com/
[7] https://www.drugpatentwatch.com/solifenacin/patent
[8] https://www.fda.gov/drugs/generic-drugs/what-generic-drugs-are
[9] https://www.urologyhealth.org/urology-a-to-z/o/overactive-bladder